Neurology

The newly announced sham surgery-controlled trial will include 102 patients with moderate PD testing several…

The chief medical officer at Stoke Therapeutics discussed recent developments for zorevunersen, including the significance…

The professor and chair of the Department of Molecular Pathobiology at NYU College of Dentistry…

The phase 2, placebo-controlled, crossover trial will test whether 50 mg once daily lorundrostat may…

The chief of neuroinfectious diseases and global neurology at Northwestern Medicine discussed a recently published…

In the pivotal phase 3 Clarity AD trial, treatment with a subcutaneous autoinjector of lecanemab…

Post Content: Source: Neurology Read More

The founding director of the Optimal Aging Institute at the NYU Grossman School of Medicine…

Recent research investigated how HSV-1 infection affects tau phosphorylation through the cGAS-STING-TBK1 pathway, highlighting potential…

James Wheless, MD, FAAP, FAAN, FAES, Le Bonheur Chair in Pediatric Neurology at the University…